- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Baird Medical partners with Alpmed on ablation technology | 3 | Investing.com | ||
| Mo | Baird Medical Investment Holdings Ltd.: Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally | 706 | GlobeNewswire (Europe) | Agreement combines Baird Medical's clinical, regulatory, and global commercialization expertise with Alpmed's leadership in IRE technologyCollaboration will advance technology development, global... ► Artikel lesen | |
| 29.04. | Baird Medical Investment Holdings Limited GAAP EPS of -$0.98, revenue of $22.5M | 24 | Seeking Alpha | ||
| 29.04. | BDMD: Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update | 666 | PR Newswire | Full year 2025 revenue of $22.5 million, impacted by policy-driven slowdown in Mainland China
Advancing global expansion with appointment of seasoned commercial leader... ► Artikel lesen | |
| 24.04. | Baird Medical Investment Holdings Ltd - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
| BAIRD MEDICAL Aktie jetzt für 0€ handeln | |||||
| 10.03. | Baird Medical Investment Holdings Ltd - S-8, Securities to be offered to employees in employee benefit plans | 13 | SEC Filings | ||
| 04.03. | Baird Medical beantragt Zulassung für KI-Chirurgieplattform in USA, Europa und China | 11 | Investing.com Deutsch | ||
| 04.03. | Baird Medical begins registration for AI surgical software platform | 2 | Investing.com | ||
| 09.02. | BDMD: Baird Medical Accelerates Global Commercial Roadmap with Strategic Clinical Education Initiatives in the U.S. and Japan | 405 | PR Newswire | NEW YORK, Feb. 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation... ► Artikel lesen | |
| 03.12.25 | BDMD: Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion | 492 | PR Newswire | NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive... ► Artikel lesen |
10 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 2,180 | -0,91 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| BUTTERFLY NETWORK | 7,699 | +0,35 % | Butterfly Network, Inc. - 8-K, Current Report | ||
| BEYOND AIR | 6,250 | +1,01 % | Beyond Air Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update | Reports $1.8 million revenue for quarter ended June 30, 2026; reaffirms revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027 PMA supplement for second-generation LungFit PH system... ► Artikel lesen | |
| AXOGEN | 40,870 | -1,94 % | Axogen, Inc. Reports Second Quarter 2026 Financial Results | ALACHUA, Fla. and TAMPA, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| AETHLON MEDICAL | 2,890 | -2,69 % | Aethlon Medical, Inc.: Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier Program | Conference Call Today at 4:30 p.m. ET
SAN DIEGO, Aug. 13, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a clinical-stage medical... ► Artikel lesen | |
| AVANOS MEDICAL | 21,600 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 27.07.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 27.07.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 27.07.2026.ISIN NameCA05335P1099 AUXLY... ► Artikel lesen | |
| APYX MEDICAL | 2,620 | -0,76 % | Apyx Medical Corp - 8-K, Current Report | ||
| ANGIODYNAMICS | 13,500 | -0,74 % | AngioDynamics auf Canaccord Genuity Konferenz: Strategiewechsel zu MedTech-Wachstum wird vertieft | ||
| ANTERIS TECHNOLOGIES GLOBAL | 9,080 | +1,57 % | Anteris Technologies Global Corp.: Anteris Technologies Announces Results for the Second Quarter of 2026 | MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ: AVR, ASX: AVR) a global healthcare company committed... ► Artikel lesen | |
| ADAPTHEALTH | 5,805 | +0,18 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 6,750 | 0,00 % | Autonomix Medical, Inc.: Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission | ||
| BLUEJAY DIAGNOSTICS | 1,060 | +0,95 % | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony IL-6 Toward Regulatory Submission and Commercialization | SYMON-II pivotal clinical study completes targeted enrollment of 750 patientsCompany advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate... ► Artikel lesen | |
| AGAPE ATP | 2,480 | +1,00 % | Agape ATP Corp - 10-Q, Quarterly Report | ||
| BONE BIOLOGICS | 0,670 | 0,00 % | BONE BIOLOGICS CORPORATION: Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities | BURLINGTON, Mass, July 23, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) ("Bone Biologics" or the "Company"), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| ADVANCED BIOMED | 8,800 | +0,47 % | Morning Market Movers: InMed Pharmaceuticals, INLIF Limited, China SXT Pharmaceuticals, Advanced Biomed See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
Das Unternehmen BAIRD MEDICAL INVESTMENT HOLDINGS LTD kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,140 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BAIRD MEDICAL INVESTMENT HOLDINGS LTD finden Sie auf Wallstreet Online.